Tesamorelin
Stabilised GHRH analogue researched for visceral fat reduction and IGF-1 elevation.
Recon & Dosing
Open the calculator for Tesamorelin vials.
- Category
- Growth Hormone
- Half-life
- ~30–40 minutes
- Typical vial
- 5 mg / 10 mg lyophilised
- Reported research dose
- 1–2 mg daily in clinical arms
Mechanism of action
Trans-3-hexenoyl stabilised GHRH(1-44) with resistance to enzymatic degradation.
Storage & handling
Refrigerate; reconstitute immediately before use where possible.
Run the reconstitution math →Research notes
- One of the few GH-axis peptides with an FDA-approved indication.
Research use only. Figures above summarise published literature and community protocols for reference. Nothing here is a recommendation for human use.